The management of thyroid dysfunction is structured into three main phases: screening, diagnostic confirmation, and therapeutic follow-up.
Initial treatment often involves antithyroid drugs (block synthesis). Other options include radioactive iodine (iratherapy) or surgery for toxic nodules. Resource Review for Practitioners
The standard treatment is Levothyroxine (L-T4) . For subclinical cases, treatment depends on TSH levels (typically >10 mIU/L) and cardiovascular risk factors.
Further tests like anti-TPO antibodies or thyroid ultrasound are used only when an etiology (such as Grave’s or Hashimoto’s) needs to be confirmed. Management Strategies:
For those looking to download official PDF protocols, several authoritative sources provide structured guides:
In most clinical settings, a TSH assay is the only test recommended for first-line screening.
If TSH is abnormal, free T4 (fT4) is measured to distinguish between subclinical and overt disease.
